
Join to view full profile
3901 Rainbow BlvdKansas City, KS 66160
Phone+1 913-588-5000
Fax+1 816-302-9939
Dr. Gerson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Children's Mercy Kansas CityNeurology, 2020
University of Missouri-Kansas City School of MedicineFellowship, Neurology, 2020
University of Kansas School of MedicineResidency, Neurology, 2015 - 2019
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2015
Certifications & Licensure
KS State Medical License 2015 - 2027
MO State Medical License 2019 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Gold Humanism Award Gold Humanism Honors Society, 2015
Publications & Presentations
PubMed
- 1 citationsThe Real-World Evaluation of Remote Electrical Neuromodulation in Pediatric Migraines: A Preliminary Study.Amit Blumovich, Trevor Gerson, Mark Connelly, Tammie Wingert, Gina Jones
Children. 2025-11-05 - Atypical Melanocytic Cells in the Cerebrospinal Fluid of a 7-Year-Old Child With Headaches.Weijie Li, Suzanne Schauwecker, Trevor Gerson
International Journal of Laboratory Hematology. 2025-08-01 - 8 citationsAcute treatment of migraine in children aged 6-11: Real-world analysis of remote electrical neuromodulation (REN).Klaus Werner, Trevor Gerson, Alit Stark-Inbar, Sharon Shmuely, Alon Ironi
Annals of the Child Neurology Society. 2024-06-01
Press Mentions
Nerivio Device Cleared for Pediatric Migraine TreatmentNovember 15th, 2024
FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and AboveNovember 14th, 2024
New Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12July 25th, 2024
Professional Memberships
- Member
- American Headache SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









